Treatments Compared for Pediatric-Onset Multiple Sclerosis
More pediatric patients free of new or newly enlarging T2 lesions at week 96 with dimethyl fumarate versus interferon beta-1a
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.